TrialNeuropsychopharmacology reports2023

Efficacy and safety of adding fluoxetine to the treatment regimen of hospitalized patients with non-critical COVID-19 pneumonia: A double-blind randomized, placebo-controlled clinical trial.

Faranak Sedighi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.